Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. - Wikidata - awgldk - TriplyDB

Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent.

Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent.

http://www.wikidata.org/entity/Q38350940

about

Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism Heterodimeric interaction and interfaces of S100A1 and S100P Sperm-associated antigen 1 is expressed early in pancreatic tumorigenesis and promotes motility of cancer cells S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer The life and works of S100P - from conception to cancer Periostin-like-factor and Periostin in an animal model of work-related musculoskeletal disorder Bioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic/therapeutic biomarkers Pancreatic Expression database: a generic model for the organization, integration and mining of complex cancer datasets.New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8.Pancreatic cancer.Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes.Integrative prescreening in analysis of multiple cancer genomic studies.Tissue biomarkers of breast cancer and their association with conventional pathologic features.Regularized gene selection in cancer microarray meta-analysis Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.Genome-scale analysis identifies GJB2 and ERO1LB as prognosis markers in patients with pancreatic cancer.S100P: a novel therapeutic target for cancer.Integrative analysis and variable selection with multiple high-dimensional data sets Using BioMart as a framework to manage and query pancreatic cancer data.A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma.Proteome of formalin-fixed paraffin-embedded pancreatic ductal adenocarcinoma and lymph node metastases.Matrix-assisted laser desorption/ionization mass spectrometry reveals decreased calcylcin expression in small cell lung cancer.Retinoid signaling in pancreatic cancer, injury and regeneration.MALDI MS imaging as a tool for biomarker discovery: methodological challenges in a clinical setting.Molecular analysis of precursor lesions in familial pancreatic cancer Genetics and pathology of pancreatic cancer.High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.S100P expression is a novel prognostic factor in hepatocellular carcinoma and predicts survival in patients with high tumor stage or early recurrent tumors.Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays CD109 Overexpression in Pancreatic Cancer Identified by Cell-Surface Glycoprotein Capture.Overexpression of COL11A1 by cancer-associated fibroblasts: clinical relevance of a stromal marker in pancreatic cancer.S100P, a calcium-binding protein, is preferentially associated with the growth of polypoid tumors in colorectal cancer.Further characterization of HDAC and SIRT gene expression patterns in pancreatic cancer and their relation to disease outcome The influence of SnoN gene silencing by siRNA on the cell proliferation and apoptosis of human pancreatic cancer cells.Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer.Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models.Clinical significance of the integrin α6β4 in human malignancies.Proteomic profiling of pancreatic cancer for biomarker discovery.

P2860

Q21144683-D9E6A605-510A-45F3-8987-A749CDB32388 Q24294738-BAEE3EDF-C3E2-4D5F-9A63-7D365826BB8D Q24303925-DC79648E-F052-424D-9783-A9FD48AEC701 Q24311937-1A4830BA-0FA9-44FC-8076-A6CDB59C46D5 Q24316003-EDC05E49-4DF8-4104-8821-EBAC0FB85981 Q24337345-F905AB17-97C4-4D04-B598-3D9682D6FB13 Q26749135-23300FD9-2FF0-4DEA-B5E8-2576A6777AF2 Q28386686-D207A789-3A33-4025-BD87-D4DB2F1D8A14 Q28834154-023CCBCF-C9E0-45F5-B2C3-DF902479C07F Q30483618-46DA9ECF-4686-48B9-B213-B30B31F73AB3 Q30489770-6E7E7AFE-60F9-4107-9283-29747C148D84 Q30490247-5DB394F4-2561-4A3F-B6E0-B4907B9560D2 Q30989925-EEFF0955-CB16-4F62-9396-E4D69D9A04DA Q31072766-073AC7C7-F211-4BC3-ACF4-465FC18E5004 Q31110635-80C8605C-99CA-4412-9349-38138BEF2B52 Q33396835-BB06FDB8-8B52-4BB1-8548-9E802DEF9FB7 Q33514817-927801A9-C625-4022-938A-E6487D1CD604 Q33591508-8D3A7487-6C9B-4D0F-9777-FAE85E31D921 Q33699305-A2632DBF-07AA-46F6-9A29-71685591B3DF Q33849612-7F02BC43-6312-4668-B5F6-DBE0AA8F6EB0 Q33930352-DDD30C19-F1EF-4CDD-9ABF-3C5C05DCE753 Q33992146-937B91C7-88C9-45BE-8872-B9F4861E422C Q34073892-63070802-076A-467B-8A93-2278FBCBBCD9 Q34109148-868FA6B5-CD92-423A-A24A-FE3E16A824C8 Q34119073-05F8DCCA-B9F5-40E6-93A1-E2A7E9A0A768 Q34454885-B7F59BF5-2923-439C-8BD3-C3532A8858C7 Q34571373-89E2D80E-455D-422F-84F2-6E4BD6D19366 Q34589293-EDB4E7AE-6C27-44B0-B3F9-864B2299DDB8 Q34721443-B41F1228-25AE-4EF0-8C05-5160BB26F630 Q34778723-62284A68-EF74-4C90-A508-CF1D3ACDEC3B Q34928555-D32BA3B8-1936-4A34-910A-938F57B21DC7 Q35017547-127FCD66-7D95-458D-8CA0-E42A2927899B Q35032539-C7A36D59-3D57-49C0-9DCC-2D655502A7F0 Q35040035-1008958E-41C6-423C-8E3E-BB99483BF3B1 Q35294688-34F9AE04-E57D-4D8C-AA5C-CAF4D3B18EDA Q35532374-9BE84481-785D-4C39-828C-C31943200F36 Q35576601-020836E0-FA88-4FCB-8244-23074098FE1E Q35702968-CC91DAE4-0D0B-4341-B993-A1404118E8B8 Q36010634-3EC4B808-151D-45B4-9FDA-50912B67CB3C Q36026306-E0A1CBDB-D13C-416B-AD8C-DBBC0089CD10

P2860

Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent.

http://www.wikidata.org/entity/Q38350940

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Molecular alterations in pancr ...... 100 genes is highly prevalent.

@en

type

label

Molecular alterations in pancr ...... 100 genes is highly prevalent.

@en

prefLabel

Molecular alterations in pancr ...... 100 genes is highly prevalent.

@en

P1433

Q38350940-A06DD397-F615-4D35-A7D6-D6527A18B979

P1476

Q38350940-EAD52440-1CC9-452C-B88D-A105289AD8C0

P2093

Q38350940-0330DC0A-E8D7-4ACB-93B3-400A20A42B92

Q38350940-2A13071B-DAF8-4759-B98F-244693C60160

Q38350940-2E083128-8E09-4505-B22E-46C88CAEC5C0

Q38350940-43D24BD1-40A8-4ED6-8CDC-34F11D9B78D3

Q38350940-52203FDD-0733-4158-B095-9BA71EC133B4

Q38350940-D5EFC6D7-F28D-41C0-BFA5-4A9A62A88AAB

P2860

Q38350940-14BB95E8-9CBD-4F0B-8DCC-929242411F38

Q38350940-86B60CB5-22F2-41A5-9788-12CA7F55FD4B

Q38350940-8BC4135F-B8F2-44A5-82FB-1A7AE02723A7

P304

Q38350940-FA0F5392-CA02-4535-852E-BEE6B1CE8F22

P31

Q38350940-2A8FE15C-6774-486D-A837-BECCF99056A2

P356

Q38350940-67EFF4DE-307B-4554-B9CB-23812CA7B9C1

P433

Q38350940-3729D343-E833-4F92-9C35-5D423821BC19

P478

Q38350940-AD61DA13-51EE-4024-A9EB-C0C1E6C99F61

P50

Q38350940-171539CF-E892-40CD-9B74-66C64C99B958

Q38350940-AC599150-D350-496A-9FD4-328F77334825

Q38350940-C09EB3C9-E59B-4292-B284-B3FB8ED7A027

P577

Q38350940-3972C8A6-B585-4A78-AE9F-4433BB767334

P698

Q38350940-8EC38E58-E27C-4EC1-AC82-0FCDE083BD4E

P356

P1433

The Journal of Pathology

P1476

Molecular alterations in pancr ...... 100 genes is highly prevalent.

@en

P2093

Benoit Terris

http://www.w3.org/2001/XMLSchema#string

Ekaterina Blaveri

http://www.w3.org/2001/XMLSchema#string

Melanie Jones

http://www.w3.org/2001/XMLSchema#string

Nicholas R Lemoine

http://www.w3.org/2001/XMLSchema#string

Rathi Gangeswaran

http://www.w3.org/2001/XMLSchema#string

Tatjana Crnogorac-Jurcevic

http://www.w3.org/2001/XMLSchema#string

P2860

Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation.

Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.

Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas.

P304

63-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PATH.1418

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

201

http://www.w3.org/2001/XMLSchema#string

P50

John P Neoptolemos

Edoardo Missiaglia

Eithne Costello

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12950018

http://www.w3.org/2001/XMLSchema#string